JUBILANT PHARMOVA LIMITED — Regulatory Filings 2024

Mar 29, 2024

==> picture [107 x 74] intentionally omitted <==

March 29, 2024

BSE Limited

Floor 25, P. J. Towers Dalal Street, Fort Mumbai - 400 001

National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex, Bandra (E) Mumbai - 400 051

Scrip Code: 530019

Symbol: JUBLPHARMA

Dear Sirs,

Sub: Compliance under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/MIRS/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, we wish to inform that on March 29, 2024 , the following share certificates has been reported to be lost to the Company as stated below:

inform that onMarch 29, 20 as stated below:	24, the following share ce	rtificates has been reported to	be lost to the Company
Name and Folio No.	Certificate No.	Distinctive No.	No. of Shares
Ramotar Agarwala Folio no-11550	206528	138893476-138893775	300
Lalita Devi Agarwala jointly with Dipti Bhavanji Dedhia Folio no-6718	203787	136743336-136743635	300

The claimant has requested for issuance of duplicate share certificate/ dematerialization of Shares in lieu of the original.

We propose to issue letter of confirmation to the claimant on receipt of the requisite documents.

We request you to caution your members not to deal in or make any transaction in these shares.

This is for your information and record. Thanking you,

Yours faithfully,

For Jubilant Pharmova Limited

Digitally signed by Naresh Kapoor Naresh Kapoor Date: 2024.03.29 16:45:27 +05'30' Naresh Kapoor Company Secretary

==> picture [566 x 106] intentionally omitted <==